Drug distributor Cardinal Health raised its 2026 profit forecast on Tuesday, driven by robust demand for specialty medicines ...
Cardinal Health Earnings: Resilient Demand, Strategic Acquisitions Help Slightly Exceed Expectations
Narrow-moat Cardinal Health reported solid third-quarter earnings that came in a touch higher than our expectations. Total sales of $54.9 billion were flat year over year, but up 19% when adjusted for ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics and targeted therapeutics for cancer, today announced publication of “The Drive for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback